BIFIDO Co. Ltd (238200) - Total Liabilities
Based on the latest financial reports, BIFIDO Co. Ltd (238200) has total liabilities worth ₩12.57 Billion KRW (≈ $8.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BIFIDO Co. Ltd equity growth rate to track the company's year-over-year net asset growth rate.
BIFIDO Co. Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how BIFIDO Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 238200 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
BIFIDO Co. Ltd Competitors by Total Liabilities
The table below lists competitors of BIFIDO Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cherry AG
XETRA:C3RY
|
Germany | €73.87 Million |
|
Magnum Ventures Limited
NSE:MAGNUM
|
India | Rs5.24 Billion |
|
Principal Technologies Inc
V:PTEC
|
Canada | CA$1.32 Million |
|
Orege Société Anonyme
PA:OREGE
|
France | €60.58 Million |
|
CANADIAN NORTH RESOURCES
F:EO0
|
Germany | €3.30 Million |
|
Auris Minerals Ltd
AU:AUR
|
Australia | AU$368.94K |
|
Chorokbaem Healthcare Co Ltd
KO:118000
|
Korea | ₩66.98 Billion |
|
Denali Capital Acquisition Corp. Class A Ordinary Shares
NASDAQ:DECA
|
USA | $11.16 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down BIFIDO Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BIFIDO Co. Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BIFIDO Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BIFIDO Co. Ltd (2016–2025)
The table below shows the annual total liabilities of BIFIDO Co. Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩15.37 Billion ≈ $10.42 Million |
+5.82% |
| 2024-12-31 | ₩14.53 Billion ≈ $9.84 Million |
-27.49% |
| 2023-12-31 | ₩20.03 Billion ≈ $13.58 Million |
+718.48% |
| 2022-12-31 | ₩2.45 Billion ≈ $1.66 Million |
-38.89% |
| 2021-12-31 | ₩4.01 Billion ≈ $2.71 Million |
-40.25% |
| 2020-12-31 | ₩6.70 Billion ≈ $4.54 Million |
+243.69% |
| 2019-12-31 | ₩1.95 Billion ≈ $1.32 Million |
-3.14% |
| 2018-12-31 | ₩2.01 Billion ≈ $1.36 Million |
-89.03% |
| 2017-12-31 | ₩18.35 Billion ≈ $12.44 Million |
+0.47% |
| 2016-12-31 | ₩18.27 Billion ≈ $12.38 Million |
-- |
About BIFIDO Co. Ltd
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.